Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance. [electronic resource]
Producer: 20151109Description: 63-71 p. digitalISSN:- 1449-1907
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Berberine -- administration & dosage
- Biomarkers, Tumor -- genetics
- Bone Morphogenetic Protein 7 -- genetics
- Cell Line, Tumor
- Cell Movement -- drug effects
- Dose-Response Relationship, Drug
- Epithelial-Mesenchymal Transition -- drug effects
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Kaplan-Meier Estimate
- Male
- Nodal Protein -- genetics
- Prognosis
- Prostatic Neoplasms -- drug therapy
- Wnt Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.